These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7371683)

  • 1. Antibody and antigen levels in rats inoculated with Moloney sarcomas and viral antigens.
    Soderberg F; Jones JM
    Eur J Cancer (1965); 1980 Feb; 16(2):285-8. PubMed ID: 7371683
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.
    Lavrin DH; Herberman RB; Nunn M; Soares N
    J Natl Cancer Inst; 1973 Nov; 51(5):1497-508. PubMed ID: 4762933
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic control of immune responses to Moloney sarcomas in rats: role of non-RT-1 background genes.
    Jones JM
    Int J Cancer; 1983 Aug; 32(2):227-30. PubMed ID: 6409816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
    Biasi G; Facchinetti A; Panozzo M; Zanovello P; Chieco-Bianchi L; Collavo D
    J Immunol; 1991 Oct; 147(7):2284-9. PubMed ID: 1833453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
    Epstein LB; Knight RA
    Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with p30 enhances the growth of a rat Moloney sarcoma.
    Jones JM; Kennel SJ; Feldman JD
    J Immunol; 1977 Jan; 118(1):371-3. PubMed ID: 830759
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiolabeled antitumor antibodies. III. Highly iodinated and highly radioiodinated antibodies.
    Nord S; Weissman IL
    J Natl Cancer Inst; 1974 Oct; 53(4):959-65. PubMed ID: 4473559
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-surface and virion-envelope antigens shared by radiation leukemia virus (RadLV) and other murine c-type viruses.
    Ferrer JF
    Int J Cancer; 1973 Sep; 12(2):378-88. PubMed ID: 4134124
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumour activity in vitro dependent on immune B lymphocytes.
    Lamon EW; Wigzell H; Andersson B; Klein E
    Nat New Biol; 1973 Aug; 244(137):209-11. PubMed ID: 4542206
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immunity to viral proteins in mice bearing Moloney sarcomas.
    Koppi TA; Halliday WJ
    Immunol Lett; 1982 Mar; 4(3):135-40. PubMed ID: 7076284
    [No Abstract]   [Full Text] [Related]  

  • 13. Moloney cell surface antigen (MCSA) has properties of an env gene product that is serologically distinct from the env gene products of the Moloney strain of murine leukemia virus.
    Hesselink WG; van der Kemp AC; Bloemers HP
    Virology; 1981 Apr; 110(2):375-84. PubMed ID: 7194539
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM; Prehn RT
    J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation.
    Jones DB; Moore M
    Br J Cancer; 1974 Jan; 29(1):21-30. PubMed ID: 4820943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serochemotherapy against a Moloney virus-induced leukemia.
    Pearson GR; Redmon LW; Pearson JW
    Cancer Res; 1973 Aug; 33(8):1854-7. PubMed ID: 4578564
    [No Abstract]   [Full Text] [Related]  

  • 17. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor specific antigens in viral neoplasms and in unrelated virus infected tumors.
    Sjögren HO
    Ann Med Exp Biol Fenn; 1966; 44(2):227-31. PubMed ID: 4290659
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic control of antibody responses to Moloney virus in rats.
    Jones JM; Günther E; Soderberg FB
    Leuk Res; 1982; 6(1):127-9. PubMed ID: 7070110
    [No Abstract]   [Full Text] [Related]  

  • 20. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS
    J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.